- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 389
One Kings Lane goes to Bed Bath & Beyond
Bed Bath & Beyond has acquired Scripps-backed home furnishings flash sales platform One Kings Lane for a sum likely to be far less than its $912m series E valuation.
Jun 15, 2016DraftKings and FanDuel mull billion-dollar merger
The daily fantasy sports businesses have raised a total of almost $750m from investors including Alphabet, Fox Sports, Time Warner, Comcast and NBC.
Jun 14, 2016Move Loot delivers acquisition news
The second-hand furniture marketplace, backed by Alphabet and IDG, is in talks to be acquired by an as-yet unnamed "symbiotic company".
Jun 14, 2016Imperial exits Alkion Biopharma
Imperial Innovations exits its investment in Imperial College London spinout Alkion Biopharma, selling its shares to chemical company Evonik Industries.
Jun 14, 2016OneLogin moors itself in Portadi
OneLogin has bought cloud app management software developer Portadi for an undisclosed amount, a year after it graduated from Microsoft Ventures Accelerator.
Jun 13, 2016China Online Education writes final IPO script
The Duowan Entertainment-backed English language learning platform has raised $45.6m in a US initial public offering and will secure another $20m through a private placement.
Jun 13, 2016Big deal: Cambridge wins big returns
Cambridge Enterprise comes out on top for money returned on investments with impressive numbers across the board.
Jun 13, 2016Smaato advertises $148m acquisition
Spearhead Integrated Marketing Communication has agreed to buy Smaato for $148m two years after the mobile advertising company raised series E funding from Singapore Press.
Jun 10, 2016Line marches towards $1bn IPO
Naver-owned messaging platform Line is set to sell 13 million shares in Japan and 22 million shares in the US priced at $26.30 each for a dual listing.
Jun 10, 2016Ergomed acquires Haemostatix
Drug developer Ergomed acquires Leicester spinout Haemostatix, which is developing a blood clotting peptide sequence, for $11.5m upfront and a potential future payment of $29m.
Jun 9, 2016About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


